The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Oct 14, 2026
Snapshot (as of Oct 14, 2026): Thermo Fisher Scientific Inc. (TMO) pays a $1.80 annual dividend ($0.47 quarterly), yielding 0.28% at $663.04/share. Next ex-dividend date 2026-09-15. 13 consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 0.28%
Annual Dividend: $1.80 per share
Payout Ratio: 9.7%
Ex-Dividend Date: 2026-09-15
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 17
Thermo Fisher Scientific Inc. dividend sits at a 0.29% yield, reflecting a company that reinvests heavily into its life sciences, diagnostics, and biopharma services businesses rather than paying out cash to shareholders. TMO pays dividends quarterly, with a trailing annual rate of $1.80 per share and a next ex-dividend date of September 15, 2026. The yield is low by income standards, but 13 consecutive years of increases point to a company that treats dividend growth as a commitment. With a beta of 0.877, TMO stock carries below-market volatility, which appeals to growth-and-income investors who want dividend momentum without sharp price swings.
Thermo Fisher Scientific Inc. pays out 9.7% of earnings as dividends, a payout ratio classified as conservative (below 40%). That leaves an unusually wide buffer: the company retains more than 90 cents of every dollar earned, funding operations across reagents, instruments, clinical diagnostics, and biopharma services without straining the dividend. Thermo Fisher Scientific Inc. dividend safety is reinforced by that low payout, though the company operates in markets where R&D spending and biopharma demand can shift, and any sustained earnings pressure would be the most direct threat to continued increases.
Thermo Fisher Scientific Inc. dividend history shows a CAGR of 9.2% per year from 2013 to 2025. The per-share annual dividend grew from $0.60 to $1.72 over that window (2026 data is partial and excluded from the CAGR calculation). The largest annual increase in the window was 18.2% in 2021. Growth is not uniform year to year, but the direction has been unbroken across 13 consecutive years of increases.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +12.7% | $1.20 (2022) | $1.72 (2025) |
| 5-Year | +14.3% | $0.88 (2020) | $1.72 (2025) |
| 10-Year | +11.1% | $0.60 (2015) | $1.72 (2025) |
Thermo Fisher Scientific Inc. fits growth-and-income investors who want dividend momentum from a life sciences and biopharma services business, not a high current payout. The yield is low (below 2%), currently at 0.29%, which is slightly above the 5-year average of 0.25% but still minimal for income-focused portfolios. What TMO offers instead is a 9.2% annualized growth rate over 12 years and a 9.7% payout ratio that leaves room for continued increases. The trade-off is straightforward: an investor gets a fast-growing dividend with almost no current income, and accepts that the yield alone will not fund near-term income needs.
| Payment Date | Amount per Share |
|---|---|
| 2026-09-15 | $0.4700 |
| 2026-06-15 | $0.4700 |
| 2026-03-13 | $0.4700 |
| 2025-12-15 | $0.4300 |
| 2025-09-15 | $0.4300 |
| 2025-06-13 | $0.4300 |
| 2025-03-14 | $0.4300 |
| 2024-12-13 | $0.3900 |
| 2024-09-13 | $0.3900 |
| 2024-06-14 | $0.3900 |
| Year | Total Dividends |
|---|---|
| 2026 | $1.4100 |
| 2025 | $1.7200 |
| 2024 | $1.5600 |
| 2023 | $1.4000 |
| 2022 | $1.2000 |
Project income from TMO with the TMO dividend calculator or track your full portfolio with the dividend tracker.